Abstract
Menopause transition is an experience all women undergo either naturally or surgically. This chapter defines the stages of menopause including mental health conditions that have been studied in various populations during these life transition periods. Symptomatology including hot flashes, night sweats, insomnia, and psychiatric symptoms is outlined and examined. Theories about the relationship between menopause and depression such as hormonal fluctuations, psychosocial, and neurobiological factors are discussed along with evidence for and against such theories. Use of hormone/estrogen therapy and its effect on depression in perimenopausal and postmenopausal women is also discussed in this chapter. Surgical versus natural menopause is outlined with evidence suggesting many factors interplay with regard to depression and surgical menopause. Implications for treatment of various psychiatric disorders including anxiety, bipolar disorder, and schizophrenia are discussed. Finally, evidence is presented that shows an increase in sexual dysfunction during menopause transition due to multiple factors including no partner, depressed mood, or living with a child. Treatment implications are included to guide care providers working with women who are undergoing this stage of life change.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander, J. L., Dennerstein, L., Woods, N. F., McEwen, B. S., Halbreich, U., Kotz, K., et al. (2007). Role of stressful life events and menopausal stage in wellbeing and health. Expert Review of Neurotherapies, 7(Suppl. 11), 93–113.
Almeida, O. P., Lautenschlager, N., Vasikaram, S., Leedman, P., & Flicker, L. (2005). Association between physiological serum concentration of estrogen and the mental health of community-dwelling postmenopausal women age 70 years and over. American Journal of Geriatric Psychiatry, 13(2), 142–149.
Aloysi, A., Van Dyk, K., & Sano, M. (2006). Women’s cognitive and affective health and neuropsychiatry. Mount Sinai Journal of Medicine, 73(7), 967–975.
Amore, M., Di Donato, P., Papalini, A., Berti, A., Palareti, A., Ferrari, G., et al. (2004). Psychological status at the menopausal transition: An Italian epidemiological study. Maturitas, 48(2), 115–124.
Amsterdam, J., Garcia-España, F., Fawcett, J., Quitkin, F., Reimherr, F., Rosenbaum, J., et al. (1999). Fluoxetine efficacy in menopausal women with and without estrogen replacement. Journal of Affective Disorders, 55, 11–17.
Avis, N. E., Brambilla, D., McKinlay, S. M., & Vass, K. (1994). A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women’s Health Study. Annals of Epidemiology, 4(3), 214–220.
Avis, N. E., Crawford, S., Stellato, R., & Longcope, C. (2001). Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric, 4(3), 243–249.
Avis, N. E., Kaufert, P. A., Lock, M., McKinlay, S. M., & Vass, K. (1993). The evolution of menopausal symptoms. Baillieres Clinical Endocrinology and Metabolism, 7(1), 17–32.
Avis, N. E., & McKinlay, S. M. (1991). A longitudinal analysis of women’s attitudes toward the menopause: Results from the Massachusetts Women’s Health Study. Maturitas, 13(1), 65–79.
Avis, N. E., & McKinlay, S. M. (1995). The Massachusetts Women’s Health Study: An epidemiologic investigation of the menopause. Journal of American Medical Women’s Association, 50(2), 45–49.
Aziz, A., Brannstrom, M., Berquist, C., & Silfverstolpe, G. (2005). Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertility and Sterility, 83, 1021–1028.
Ball, P., Knuppen, R., Haupt, M., & Breuer, H. (1972). Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. Journal of Clinical Endocrinology Metabolism, 34(4), 736–746.
Biegon, A. (1990). Effects of steroid hormones on the serotonergic system. Annals of the New York Academy of Sciences, 600, 426–432.
Blehar, M. C., DePaulo, J. R. Jr., Gershon, E. S., Reich, T., Simpson, S. G., & Nurnberger, J. I. Jr. (1998). Women with bipolar disorder: Findings from the NIMH Genetics Initiative sample. Psychopharmacology Bulletin, 34(3), 239–243.
Booij, L., Van Der Does, W., Benkelfat, C., Bremner, J. D., Cowen, P. J., Fava, M., et al. (2002). Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology, 27(5), 852–861.
Bromberger, J. T., Assmann, S. F., Avis, N. E., Schocken, M., Kravitz, H. M., & Cordal, A. (2003). Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. American Journal of Epidemiology, 158(4), 347–356.
Burger, H., Woods, N. F., Dennerstein, L., Alexander, J. L., Kotz, K., & Richardson, G. (2007). Nomenclature and endocrinology of menopause and perimenopause. Expert Review of Neurotherapies, 7(Suppl. 11), 35–43.
Burt, V. K., Alshuler, L. L., & Rasgon, N. (1998). Depressive symptoms in the perimenopause: Prevalence, assessment, and guidelines for treatment. Harvard Review of Psychiatry, 6, 121–132.
Campbell, S., & Whitehead, M. (1977). Oestrogen therapy and the menopausal syndrome. Clinics in Obstetrics and Gynaecology, 4, 31–47.
Chang, S. H., Kim, C. S., Lee, K. S., Kim, H., Yim, S. V., Lim, Y. J., et al. (2007). Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas, 58(1), 19–30.
Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Archives of General Psychiatry, 63(4), 385–390.
Cone, R. I., Davis, G. A., & Goy, R. W. (1981). Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Research Bulletin, 7, 639–644.
Coulam, C. B., Adamson, S. C., & Annegers, J. F. (1986). Incidence of premature ovarian failure. Obstetrics and Gynecology, 67(4), 604–606.
Davies, J., & Doyle, P. (2002). Quality of life studies in unselected gynecological outpatients and inpatients before and after hysterectomy. Journal of Obstetrics and Gynecology, 22, 523–526.
Deecher, D., Andree, T. H., Sloan, D., & Schechter, L. E. (2008). From menarche to menopause: Exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology, 33, 3–17.
Deeks, A. A., & McCabe, M. P. (2004). Well-being and menopause: An investigation of purpose in life, self-acceptance and social role in premenopausal, perimenopausal and postmenopausal women. Quality of Life Research, 13(2), 389–398.
Dennerstein, L. (1996). Well-being, symptoms and the menopausal transition. Maturitas, 23(2), 147–157.
Dennerstein, L., Dudly, E., & Burger, H. (2001). Are changes in sexual functioning during midlife due to aging or menopause? Fertility and Sterility, 76, 456–460.
Dennerstein, L., Guthrie, J. R., Clark, M., Lehert, P., & Henderson V. W. (2004). A population-based study of depressed mood in middle-aged, Australian-born women. Menopause, 11(5), 563–568.
Dennerstein, L., Lehert, P., & Burger, H. (2005a). The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertility and Sterility, 84, 174–180.
Dennerstein, L., Lehert, P., Burger, H., & Dudley, E. (1999). Mood and the menopausal transition. Journal of Nervous Mental Disease, 187(11), 685–691.
Dennerstein, L., Lehert, P., Burger, H., & Guthrie, J. (2005b). Sexuality. The American Journal of Medicine, 118(12B), 59S–63S.
Dennerstein, L., Smith, A. M., & Morse, C. (1994). Psychological well-being, mid-life and the menopause. Maturitas, 20(1), 1–11.
El-Guebaly, N., Atchison, B., & Hay, W. (1984). The menopause: Stressors and facilitators. Canadian Medical Association Journal, 131(8), 865–869.
Farquhar, C., Harvey, S., Yu, Y., Sadler, L., & Stewart, A. (2006). A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy. American Journal of Obstetrics and Gynecology, 194, 711–717.
Freeman, E. W., Sammel, M. D., Lin, H., Gracia, C. R., Kapoor, S., & Ferdousi, T. (2005). The role of anxiety and hormonal changes in menopausal hot flashes. Menopause, 12, 258.
Freeman, E. W., Sammel, M. D., Liu, L., Gracia, C. R., Nelson, D. B., & Hollander, L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry, 61(1), 62–70.
Freeman, E. W., Sammel, M. D., Lin, H., Gracia, C. R., Pien, G. W., Nelson, D. B., et al. (2007). Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstetrics and Gynecology, 110(2), 230–240.
Freeman, E. W., Sammel, M. D., Lin, H., & Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63(4), 375–382.
Freeman, M. P., Smith, K. W., Freeman, S. A., McElroy, S. L., Kmetz, G. E., Wright, R., et al. (2002). The impact of reproductive events on the course of bipolar disorder in women. Journal of Clinical Psychiatry, 63(4), 284–287.
Friedman, S. H., Sajatovic, M., Schuermeyer, I. N., Safavi, R., Hays, R. W., West, J., et al. (2005). Menopause-related quality of life in chronically mentally ill women. International Journal of Psychiatry in Medicine, 35(3), 259–271.
Gordon, J. H. (1980). Modulation of apomorphine-induced stereotypy by estrogen: Time course and dose response. Brain Research Bulletin, 5(6), 679–682.
Gracia, C. R., Freeman, E. W., Sammel, M. D., Lin, H., & Mogul, M. (2007). Hormones and sexuality during transition to menopause. Obstetrics and Gynecology, 109(4), 831–840.
Graziottin, A. (2007). Prevalence and evaluation of sexual health problems—HSDD in Europe. Journal of Sexual Medicine, 4(Suppl. 3), 211–219.
Guicheney, P., Leger, D., Barrat, J., Trevoux, R., De Lignieres, B., Roques, P., et al. (1988). Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: Variations with plasma oestrogen levels and depressive symptoms. European Journal of Clinical Investigation, 18(3), 297–304.
Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., & Wang, K. (1995). Estrogen augments serotonergic activity in postmenopausal women. Biological Psychiatry, 37, 434–341.
Hallonquist, J. D., Seeman, M. V., Lang, M., & Rector, N. A. (1993). Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry, 33(3), 207–209.
Harlow, B. L., Cramer, D. W., & Annis, K. M. (1995). Association of medically treated depression and age at natural menopause. American Journal of Epidemiology, 141(12), 1170–1176.
Harlow, B. L., & Signorello, L. B. (2000). Factors associated with early menopause. Maturitas, 35(1), 3–9.
Harlow, B. L., Wise, L. A., Otto, M. W., Soares, C. N., & Cohen, L. S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with menopausal transition: The Harvard Study of Moods and Cycles. Journal of Women’s Health and Gender Based Medicine, 60, 29–36.
Hartmann, U., Philippsohn, S., Heiser, K., & Ruffer-Hesse, C. (2004). Low sexual desire in midlife and older women: Personality factors, psychosocial development, present sexuality. Menopause, 11(6), 726–740.
Hunter, M. (1992). The south-east England longitudinal study of the climacteric and postmenopause. Maturitas, 14(2), 117–26.
Joffe, H., Hall, J. E., Soares, C. N., Hennen, J., Reilly, C. J., Carlson, K., et al. (2002). Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause, 9, 392.
Kaufert, P. A., Gilbert, P., & Tate, R. (1992). The Manitoba Project: A re-examination of the link between menopause and depression. Maturitas, 14(2), 143–155.
Kjerulff, K., Langenberg, P., Rhodes, J., Harvey, L. A., Guzinski, G. M., & Stolley, P. D. (2000). Effectiveness of hysterectomy. Obstetrics and Gynecology, 95(3), 319–326.
Klaiber, E. L., Broverman, D. M., Vogel, W., & Kobayashi, Y. (1979). Estrogen therapy for severe persistent depressions in women. Archives of General Psychiatry, 36, 550–554.
Kravitz, H. M., Ganz, P. A., Bromberger, J., Powell, L. H., Sutton-Tyrrel, K., & Meyer, P. M. (2003). Sleep difficulty in women at midlife: A community survey of sleep and the menopausal transition. Menopause, 10, 19–28.
Kuh, D. L., Wadsworth, M., & Hardy, R. (1997). Women’s health in midlife: The influence of the menopause, social factors and health in earlier life. British Journal of Obstetrics and Gynaecolgy, 104, 923–933.
Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., & Tondo, L. (1980). Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatrie Neuropsychopharmakologie, 13(4), 156–167.
Kumar, M. S., Chen, C. L., & Muther, T. F. (1979). Changes in the pituitary and hypothalamic content of methionine-enkephalin during the estrous cycle of rats. Life Sciences, 25(19), 1687–1696.
Landau, S., & Milan, F. B. (1996). Assessment and treatment of depression during the menopause: A preliminary report. Menopause, 3, 201–207.
Leppert, P. C., Legro, R. S., & Kjerulff, K. H. (2007). Hysterectomy and loss of fertility: Implications for women’s mental health. Journal of Psychosomatic Research, 63, 269–274.
Liao, K. L., Wood, N., & Conway, G. S. (2000). Premature menopause and psychological well-being. Journal of Psychosomatic Obstetrics and Gynecology, 21(3), 167–174.
Lindamer, L. A., Lohr, J. B., Harris, M. J., & Jeste, D. V. (1997). Gender, estrogen, and schizophrenia. Psychopharmacology Bulletin, 33(2), 221–228.
Luine, V. N., Khylchevskaya, R. I., & McEwen, B. (1975). Effect of gonadal steroids on activities of monoaminooxidase and choline acetylase in rat brain. Brain Research, 86, 293–306.
Maciejewski, P. K., Prigerson, H. G., & Mazure, C. M. (2001). Sex differences in event-related risk for major depression. Psychological Medicine, 31(4), 593–604.
Martens, L. W., Leusink, G. L., Knottnerus, J. A., Smeets, C. G., & Pop, V. J. (2001). Climacteric complaints in the community. Family Practice, 18, 189–194.
Matthews, K. A. (1992). Myths and realities of the menopause. Psychosomatic Medicine, 54, 1–9.
McKinlay, S. M. (1996). The normal menopause transition: An overview. Maturitas, 23, 137–145.
McKinlay, S. M., & Jefferys, M. (1974). The menopausal syndrome. British Journal of Preventive and Social Medicine, 28, 108–115.
McKinlay, J. B., McKinlay, S. M., & Brambilla, D. (1987). The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. Journal of Health and Social Behavior, 28(4), 345–363.
Meltzer, H. Y. (1990). Role of serotonin in depression. Annals of the New York Academy of Sciences, 600, 486–500.
Mitchell, E. S., & Woods, N. F. (1996). Symptom experiences of midlife women: Observations from the Seattle Midlife Women’s Health Study. Maturitas, 25(1), 1–10.
Moreno, F. A., McGahuey, C. A., Freeman, M. P., & Delgado, P. L. (2006). Sex differences in depressive response during monoamine depletions in remitted depressive subjects. Journal of Clinical Psychiatry, 67(10), 1618–1623.
Morrison, J. H., Brinton, R. D., Schmidt, P. J., & Gore, A. C. (2006). Estrogen, menopause, and the aging brain: How basic neuroscience can inform hormone therapy in women. Journal of Neuroscience, 26(41), 10332–10348.
Morrison, M. F., Kallan, M. J., Have, T. T., Katz, I., Tweedy, K., & Battistini, M. (2004). Lack of efficacy of estadiol for depression in postmenpausal women: A randomized, controlled trial. Biological Psychiatry, 55, 406–412.
National Institutes of Health. (2005, March 21–23). NIH State-of-the-Science Conference Statement on Management of Menopause-Related Symptoms. State-of-the-Science Conference Statement.
Nelson, D. B., Sammel, M. D., Freeman, E. W., Liu, L., Langan, E., & Gracia, C. R. (2004). Predicting participation in prospective studies of ovarian aging. Menopause, 11(5), 543–548.
Nelson, H. D., Vesco, K. K., Haney, E., Fu, R., Nedrow, A., Miller, J., et al. (2006). Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. Journal of the American Medical Association, 295(17), 2057–2071.
North American Menopause Society. (2000). Clinical challenges of perimenopause: Consensus opinion of the North American Menopause Society. Menopause, 7, 5–13.
Novaes, C., Almeida, O. P., & de Melo, N. R. (1998). Mental health among perimenopausal women attending a menopause clinic: Possible association with premenstrual syndrome? Climacteric, 1(4), 264–270.
Osborn, M., Hawton, K., & Gath, D. (1988). Sexual dysfunction among middle-aged women in the community. British Medical Journal, 296, 959–962.
Pham, K. C., Grisso, J. A., & Freeman, E. W. (1997). Ovarian Aging and Hormone Replacement Therapy Hormonal Levels, Symptoms, and Attitudes of African-American and White Women. Journal of General Internal Medicine, 12, 230–236.
Prange, A. J., Wilson, I. C., & Alltop, L. B. (1972). Estrogen may well affect response to antidepressants. Journal of the American Medical Association, 219, 143–144.
Rapkin, A. J., Mikacich, J. A., Moatakef-Imani, B., & Rasgon, N. (2002). The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Current Psychiatry Reports, 4(6), 419–428.
Rasgon, N. L., Dunkin, J., Fairbanks, L., Altshuler, L. L., Troung, C., Elman, S., et al. (2007). Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. Journal of Psychiatric Research, 41(3–4), 338–343.
Rasgon, N., Shelton, S., & Halbreich, U. (2005). Perimenopausal mental disorders: Epidemiology and phenomenology. CNS Spectrums, 10(6), 471–478.
Reed, S. D., Newton, K. M., LaCroix, A. Z., Grothaus, L. C., & Ehrlich, K. (2007). Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: Baseline data from the Herbal Alternative for Menopause Trial (HALT). American Journal of Obstetrics and Gynecology, 196, 593.e1–593.e7.
Rehman, H. U., & Masson, E. A. (2005). Neuroendocrinology of female aging. Gender Medicine, 2(1), 41–56.
Riecher-Rössler, A., Häfner, H., Dütsch-Strobel, A., Oster, M., Stumbaum, M., van Gülick-Bailer, M., et al. (1994). Further evidence for a specific role of estradiol in schizophrenia? Biological Psychiatry, 36(7), 492–494.
Rödström, K., Bengtsson, C., Lissner, L., Milsom, I., Sundh, V., & Björkelund, C. (2002). A longitudinal study of the treatment of hot flushes: The population study of women in Gothenburg during a quarter of a century. Menopause, 9(3), 156–161.
Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., et al. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26(2), 191–208.
Sajatovic, M., Friedman, S. H., Schuermeyer, I. N., Safavi, R., Ignacio, R. V., Hays, R. W., et al. (2006). Menopause knowledge and subjective experience among peri- and postmenopausal women with bipolar disorder, schizophrenia and major depression. Journal of Nervous Mental Disease, 194(3), 173–178.
Saletu, B., Brandstatter, N., Metka, M., Stamenkovic, M., Anderer, P., Semlitsch, H. V., et al. (1996). Hormonal syndromal and EEG mapping studies in menopausal syndrome patients with and without depression compared with controls. Maturitas, 23, 91–105.
Santoro, N., Brown, J. R., Adel, T., & Skurnick, J. H. (1996). Characterization of reproductive hormonal dynamics in the perimenopause. Journal of Clinical Endocrinology & Metabolism, 81(4), 1495–1501.
Schmidt, P. J. (2005). Mood, depression, and reproductive hormones in the menopausal transition. American Journal of Medicine, 118(Suppl. 12B), 54–58.
Schmidt, P. J., Haq, N., & Rubinow, D. R. (2004a). A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. American Journal of Psychiatry, 161(12), 2238–2244.
Schmidt, P. J., Murphy, J. H., Haq, N., Danaceau, M. A., & St. Clair, L. (2002). Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology, 27(8), 907–920.
Schmidt, P. J., Murphy, J. H., Haq, N., Rubinow, D. R., & Danaceau, M. A. (2004b). Stressful life events, personal losses, and perimenopause-related depression. Archives of Women’s Mental Health, 7(1), 19–26.
Schmidt, P. J., & Rubinow, D. R. (2006). Reproductive ageing, sex steroids and depression. The Journal of the British Menopause Society, 12(4), 178–185.
Schneider, L. S, Small, G. W., Hamilton, S. H., Bystritsky, A., Nemeroff, C. B., & Meyers, B. S. (1997). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. American Journal of Geriatric Psychiatry, 5(2), 97–106.
Shapira, B., Oppenheim, G., Zohar, J., Segal, M., Malach, D., & Belmaker, R. H. (1985). Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biological Psychiatry, 20, 576–579.
Sherwin, B. B., & Suranyi-Cadotte, B. E. (1990). Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically postmenopausal women. Biological Psychiatry, 28, 339–348.
Shifren, J. L., & Avis, N. E. (2007). Surgical menopause: Effects on psychological well-being and sexuality. Menopause, 14(3), 586–591.
Shors, T. J., & Leuner, B. (2003). Estrogen-mediated effects on depression and memory formation in females. Journal of Affective Disorders, 74, 85–96.
Simpkins, J. W. (1984). Spontaneous skin flushing episodes in the aging female rat. Maturitas, 6(3), 269–278.
Smith, A. M., Shelley, J. M., & Dennerstein, L. (1994). Self-rated health: Biological continuum or social discontinuity? Social Science and Medicine, 39(1), 77–83.
Soares, C. N., Poitras, J. R., & Prouty, J. (2003). Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs and Aging, 20, 85–100.
Soules, M. R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., et al. (2001). Stages of reproductive aging workshop (STRAW). Journal of Women’s Health & Gender-Based Medicine, 10(9), 843–848.
Stewart, D. E., & Boydell, K. M. (1993). Psychologic distress during menopause: Associations across the reproductive life cycle. International Journal of Psychiatry in Medicine, 23, 157–162.
Wiegel, M., Meston, C., & Rosen, R. (2005). The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. Journal of Sex and Marital Therapy, 32, 1–20.
Williams, R. E., Kalilani, L., Dibenedetti, D. B., Zhou, X., Granger, A. L., Fehnel, S. E., et al. (2008). Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric, 11(1), 32–43.
Wise, L. A., Krieger, N., Zierler, S., & Harlow, B. L. (2002). Lifetime socioeconomic position in relation to onset of perimenopause. Journal of Epidemiology and Community Health, 56(11), 851–860.
Wood, J. M., Mansfield, P. K., & Koch, P. B. (2007). Negotiating sexual agency: Postmenopausal women’s meaning and experience of sexual desire. Qualitative Health Research, 17, 189–200.
Woods, N. F., Mariella, A., & Mitchell, E. S. (2002). Patterns of depressed mood across the menopausal transition: Approaches to studying patterns in longitudinal data. Acta Obstetricia Et Gynecologica Scandinavica, 81(7), 623–632.
Wylie, K., Daines, B., Jannini, E. A., Hallam-Jones, R., Boul, L., Wilson, L., et al. (2007). Loss of sexual desire in the postmenopausal woman. Journal of Sexual Medicine, 4(2), 395–405.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wroolie, T., Holcomb, M. (2010). Menopause. In: Levin, B., Becker, M. (eds) A Public Health Perspective of Women's Mental Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1526-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1526-9_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1525-2
Online ISBN: 978-1-4419-1526-9
eBook Packages: MedicineMedicine (R0)